PortfoliosLab logoPortfoliosLab logo
PSX vs. PFE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PSX vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Phillips 66 (PSX) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PSX achieves a 44.08% return, which is significantly higher than PFE's 8.09% return. Over the past 10 years, PSX has outperformed PFE with an annualized return of 12.61%, while PFE has yielded a comparatively lower 2.09% annualized return.


PSX

1D
-0.58%
1M
7.49%
YTD
44.08%
6M
33.41%
1Y
65.68%
3Y*
27.98%
5Y*
19.31%
10Y*
12.61%

PFE

1D
1.36%
1M
1.40%
YTD
8.09%
6M
3.39%
1Y
19.31%
3Y*
-6.48%
5Y*
-2.98%
10Y*
2.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PSX vs. PFE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PSX
Phillips 66
44.08%17.51%-11.63%33.07%49.58%8.51%-33.85%33.97%-12.28%20.94%
PFE
Pfizer Inc.
8.09%0.65%-2.22%-41.26%-10.41%66.70%3.07%-6.91%24.82%15.90%

Correlation

The correlation between PSX and PFE is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.20

Correlation (All Time)
Calculated using the full available price history since May 2, 2012

0.24

The correlation between PSX and PFE shifts across timeframes, from 0.13 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

PSX:

$73.83B

PFE:

$149.24B

EPS

PSX:

$10.17

PFE:

$1.31

PE Ratio

PSX:

18.00

PFE:

19.85

PEG Ratio

PSX:

0.10

PFE:

0.36

PS Ratio

PSX:

0.55

PFE:

2.35

PB Ratio

PSX:

2.59

PFE:

1.66

Total Revenue (TTM)

PSX:

$134.70B

PFE:

$63.32B

Gross Profit (TTM)

PSX:

$5.94B

PFE:

$43.91B

EBITDA (TTM)

PSX:

$9.17B

PFE:

$16.94B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PSX vs. PFE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSX
PSX Risk / Return Rank: 8989
Overall Rank
PSX Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
PSX Sortino Ratio Rank: 8888
Sortino Ratio Rank
PSX Omega Ratio Rank: 8787
Omega Ratio Rank
PSX Calmar Ratio Rank: 8888
Calmar Ratio Rank
PSX Martin Ratio Rank: 8989
Martin Ratio Rank

PFE
PFE Risk / Return Rank: 6767
Overall Rank
PFE Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
PFE Sortino Ratio Rank: 6464
Sortino Ratio Rank
PFE Omega Ratio Rank: 6161
Omega Ratio Rank
PFE Calmar Ratio Rank: 7272
Calmar Ratio Rank
PFE Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PSX vs. PFE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Phillips 66 (PSX) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PSXPFEDifference
Sharpe ratioReturn per unit of total volatility

+1.48

Sortino ratioReturn per unit of downside risk

+1.58

Omega ratioGain probability vs. loss probability

1.38

1.17

+0.21

Calmar ratioReturn relative to maximum drawdown

4.00

1.79

+2.20

Martin ratioReturn relative to average drawdown

11.57

3.68

+7.90

PSX vs. PFE - Sharpe Ratio Comparison

The current PSX Sharpe Ratio is 2.34, which is higher than the PFE Sharpe Ratio of 0.86. The chart below compares the historical Sharpe Ratios of PSX and PFE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PSXPFEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.34

0.86

+1.48

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.58

-0.12

+0.70

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.36

0.09

+0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

0.50

0.33

+0.17

Drawdowns

PSX vs. PFE - Drawdown Comparison

The maximum PSX drawdown since its inception was -64.21%, smaller than the maximum PFE drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for PSX and PFE.


Loading charts...

Drawdown Indicators


PSXPFEDifference

Max Drawdown

Largest peak-to-trough decline

-64.21%

-69.24%

+5.03%

Max Drawdown (1Y)

Largest decline over 1 year

-17.28%

-11.47%

-5.81%

Max Drawdown (3Y)

Largest decline over 3 years

-44.37%

-40.75%

-3.62%

Max Drawdown (5Y)

Largest decline over 5 years

-44.37%

-58.96%

+14.59%

Max Drawdown (10Y)

Largest decline over 10 years

-64.21%

-58.96%

-5.25%

Current Drawdown

Current decline from peak

-2.06%

-46.03%

+43.97%

Average Drawdown

Average peak-to-trough decline

-14.74%

-22.89%

+8.15%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.96%

5.59%

+0.37%

Volatility

PSX vs. PFE - Volatility Comparison

Phillips 66 (PSX) has a higher volatility of 8.15% compared to Pfizer Inc. (PFE) at 4.50%. This indicates that PSX's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PSXPFEDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.15%

4.50%

+3.65%

Volatility (6M)

Calculated over the trailing 6-month period

23.59%

14.66%

+8.93%

Volatility (1Y)

Calculated over the trailing 1-year period

29.47%

23.92%

+5.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.19%

25.50%

+7.69%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.31%

23.88%

+11.43%

Dividends

PSX vs. PFE - Dividend Comparison

PSX's dividend yield for the trailing twelve months is around 2.70%, less than PFE's 6.61% yield.


PositionTTM20252024202320222021202020192018201720162015
PFE
Pfizer Inc.
6.61%6.91%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%
PSX
Phillips 66
2.70%3.68%3.95%3.15%3.68%5.00%5.15%3.14%3.60%2.70%2.84%2.67%

Financials

PSX vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Phillips 66 and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B20.00B30.00B40.00B50.00B20222023202420252026
33.00B
14.45B
(PSX) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

PSX vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between Phillips 66 and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%202220232024202520260
67.3%
Portfolio components
PSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Phillips 66 reported a gross profit of 0.00 and revenue of 33.00B. Therefore, the gross margin over that period was 0.0%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.

PSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Phillips 66 reported an operating income of 0.00 and revenue of 33.00B, resulting in an operating margin of 0.0%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.

PSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Phillips 66 reported a net income of 207.00M and revenue of 33.00B, resulting in a net margin of 0.6%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.


Frequently Asked Questions


PSX and PFE have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PSX has higher volatility (8.15%) compared to PFE (4.50%). In terms of maximum drawdown, PSX dropped -64.21% vs PFE's -69.24%.

PSX currently has the higher Sharpe Ratio (2.34 vs 0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PSX and PFE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer